Filoviruses can cause severe hemorrhagic fever in humans and non-human primates.
There is an urgent need for rapid diagnosis of filoviruses during outbreaks.
Filovirus diagnostics have advanced since the 2014–2016 Ebolavirus outbreak.
NATs are the gold standard for filovirus detection.
NAT-based diagnostic speed, portability and multiplexing have all improved.
Nucleic acid testing (NAT) for pathogenic filoviruses plays a key role in surveillance and to control the spread of infection. As they share clinical features with other pathogens, the initial spread of these viruses can be misdiagnosed. Tests that can identify a pathogen in the initial stages of infection are essential to control outbreaks. Since the Ebola virus disease (EVD) outbreak in 2014–2016 several tests have been developed that are faster than previous tests and more suited for field use. Furthermore, the ability to test for a range of pathogens simultaneously has been expanded to improve clinical pathway management of febrile syndromes. This review provides an overview of these novel diagnostic tests.